From Diagnosis to Clinical Protocol: CytoMesopecia by AesMed (Part 3)
In the first two articles of this series, we introduced Korean cytokines mesotherapy ...
Read More
How AGF39™ Supports the Hair Follicle Environment (Part 2)
In Part 1, we introduced the concept of Korean cytokines mesotherapy for hair ...
Read More
What Is Korean Cytokines Mesotherapy for Hair Regrowth? (Part 1)
Hair loss is more than a visible change. For many people, it can ...
Read More
AesMed Selected as a “Global Leading Company 1,000+”
We are happy to share wonderful news with our global partners, customers, and ...
Read More
Beyond Korea, To the World: AesMed at WCHR 2026
Sharing Hair Science, Professional Care, and Patient-Centered Values with the Global Community AesMed ...
Read More
AesMed to Exhibit at WCHR 2026 in Seoul and Introduce the 1111 Hair Care Day Campaign
Connecting Hair Science, Professional Hair Loss Care, and Patient-Centered Support AesMed is pleased ...
Read More
AesMed Showcases Hair-Loss Treatment Innovations at KALDAT 2026 and KSHRS 2026
AesMed successfully participated as an exhibitor in two major medical and academic events ...
Read More
Beyond the Device: How SCALPORIN™ R1 Fits into AGF39 Protocols and the CytoMesopecia Concept
SCALPORIN™ R1 Blog Series Part 3 A professional scalp device creates the most ...
Read More
Inside SCALPORIN™ R1: AesMed’s Professional Electroporation Scalp Device for Precision Delivery
SCALPORIN™ R1 Blog Series Part 2 Once the importance of delivery in scalp ...
Read More
Why Delivery Matters in Scalp Care: Electroporation, Active Solutions, and the Logic Behind Professional Treatment
SCALPORIN™ R1 Blog Series Part 1 In professional scalp care, active ingredients often ...
Read More
